Drug-Loaded Nanospheres with “Triple-Pronged” Strategy for Triple-Negative Breast Cancer Radiotherapy
ACS Applied Nano Materials · 06.11.2026 · 9 (44) · 20554-20566
DOI: 10.1021/acsanm.6c02669 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 21.10.2026. Verfasst von Shujing Liang und 7 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Shanghai Jiao Tong University, Shanghai 2022 “Science and Technology Innovation Action Plan” Star Project, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Radiotherapy (RT) is crucial in the treatment of triple-negative breast cancer (TNBC). However, insufficient deposition of X-ray energy and peripheral tissue destruction usually caused RT failure. To circumvent this problem, herein, a “three-pronged strategy” nano-radiosensitizer (by encapsulating small molecules RSL3 and Gingerenone A (Gin A) in hollow Cu9S8 deposited with gold nanoparticles, RG@CSG) to combine with ferroptosis induction, G2/M arrest, and energy deposition is rationally designed. After passive accumulation of radiosensitizers at the tumor site, Au nanoparticles (Au NPs) grown on the surface can increase the deposition of X-ray energy to amplify the radiation-induced damage. Subsequently, upon X-ray irradiation, RG@CSG disintegrates to release RSL3 and Gin A. Gin A induces cell cycle arrest in the G2/M phase of tumor cells, which compromises DNA damage repair capacity and enhances tumor sensitivity to irradiation. RSL3 inactivates the GPX4-dependent ferroptosis defense system to eliminate residual tumor cells radioresistance. Furthermore, Au NPs can monitor the therapeutic response via activatable photoacoustic (PA) imaging in the NIR-II region (920 nm). Overall, the as-constructed RG@CSG enables a PA imaging-guided X-ray deposition-cell-cycle arrest-ferroptosis amplification cascade network, achieving a “triple-enhanced” RT sensitization strategy for effective TNBC therapy.
Förderung
- Shanghai Jiao Tong University
- Shanghai 2022 “Science and Technology Innovation Action Plan” Star Project
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Liang, S., Zou, Y., Jiao, Y., Cao, C., Cao, Y., Hao, H., Tong, X., & Cui, S. (2026). Drug-Loaded Nanospheres with “Triple-Pronged” Strategy for Triple-Negative Breast Cancer Radiotherapy. ACS Applied Nano Materials, 9(44), 20554-20566. https://doi.org/10.1021/acsanm.6c02669
Vancouver
Liang S, Zou Y, Jiao Y, Cao C, Cao Y, Hao H, et al. Drug-Loaded Nanospheres with “Triple-Pronged” Strategy for Triple-Negative Breast Cancer Radiotherapy. ACS Applied Nano Materials. 2026;9(44):20554-20566. doi:10.1021/acsanm.6c02669
BibTeX
@article{Liang2026,
author = {Liang, Shujing and Zou, Yani and Jiao, Yingao and Cao, Cheng and Cao, Yu and Hao, Huifang and Tong, Xiaohan and Cui, Shengsheng},
title = {Drug-Loaded Nanospheres with “Triple-Pronged” Strategy for Triple-Negative Breast Cancer Radiotherapy},
journal = {ACS Applied Nano Materials},
year = {2026},
volume = {9},
number = {44},
pages = {20554--20566},
doi = {10.1021/acsanm.6c02669}
}
EUVIMED